EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cerfolio, R. J.
Right arrow Articles by Schaff, H. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cerfolio, R. J.
Right arrow Articles by Schaff, H. V.

European Journal of Cardio-Thoracic Surgery, Vol 11, 479-484, Copyright © 1997 by European Association for Cardio-thoracic Surgery


ARTICLES

Reoperation for hemolytic, anaemia complicating mitral valve repair

RJ Cerfolio, TA Orszulak, RC Daly and HV Schaff
Section of Cardiovascular Surgery, Mayo Clinic, Rochester, MN 55905, USA.

OBJECTIVE: To identify the possible cause(s) of hemolysis after mitral valve repair for mitral regurgitation (MR) and to evaluate the late outcome of surgical treatment. METHODS: We reviewed all patients who had reoperation after valve repair for mitral regurgitation. Ten patients had reoperation because of hemolytic anaemia. The diagnosis of hemolysis was made by decreased serum haptoglobin, elevation of serum lactate dehydrogenase (LDH), and schistocytosis. No other causes of anaemia or hemolysis were identified in these six men and four women (ages 35-84 years; median 59 years). Interval between initial mitral valve repair and reoperation ranged from 40 to 165 days (median 87 days), and prior to reoperation, red cell transfusions (range 2-12 units; median 5 units) were required in all patients. Seven patients were symptomatic: two complained of easy fatigability and five were severely limited. Transesophageal echocardiogram during hemolytic evaluation showed only mild MR in two patients, moderate in five, moderately severe in two and severe in one. RESULTS: Etiology of hemolysis was suggested from echocardiography and confirmed at reoperation. In one patient, an eccentric MR jet struck a pledget of a commissural annuloplasty. In the remaining nine patients, the regurgitant jet struck a non-endothelialized portion of the annuloplasty ring (Carpentier-Edwards n = 5; Duran n = 2; Cosgrove- Edwards n = 2). Seven patients had prosthetic replacement and three patients had re-repair. There were no operative deaths and all patients had resolution of hemolytic anaemia. CONCLUSIONS: Relatively minor degrees of regurgitation after mitral valve repair can produce hemolytic anaemia which is manifested within the first few postoperative months. Most patients are highly symptomatic because of anaemia. The mechanism of red cell destruction is a high velocity eccentric stream of blood impacting on a small area of a prosthetic ring or pledget. This process retards endothelialization of the ring. Reoperation with re-repair or mitral valve replacement is safe and effectively relieves the hemolysis.


This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
P. Fundaro, P. M Tartara, E. Villa, P. Fratto, S. Campisi, and E. O Vitali
Mitral Valve Repair: Is There Still a Place for Suture Annuloplasty?
Asian Cardiovasc Thorac Ann, August 1, 2007; 15(4): 351 - 358.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. M. Suri, H. V. Schaff, J. A. Dearani, T. M. Sundt III, R. C. Daly, C. J. Mullany, M. Enriquez-Sarano, and T. A. Orszulak
Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired?
J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1390 - 1397.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S.-i. Oki and Y. Misawa
Hemolysis Caused by Regurgitant Blood Flow With High Shear Stress: An Intractable Complication After Mitral Valve Repair
Ann. Thorac. Surg., February 1, 2005; 79(2): 754 - 754.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B.-K. Lam, D. M. Cosgrove III, S. K. Bhudia, and A. M. Gillinov
Hemolysis after mitral valve repair: mechanisms and treatment
Ann. Thorac. Surg., January 1, 2004; 77(1): 191 - 195.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.